Lisa Wiesmüller

25PUBLICATIONS
187CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 06, 2026
Targeting common denominators of DNA damage tolerance mechanisms as therapeutic strategy to cope with dynamic phenotypic changes in triple-negative breast cancer cells.

|Apr 16, 2026
Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting against leukemogenic rearrangements at the MLL breakpoint cluster.

|Mar 01, 2026
Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification.

Rebecca Jansche, Benedikt Heitmeir, Ulrike Faust

|Oct 08, 2025
Endogenous p21 levels protect genomic stability by suppressing both excess and restrained nascent DNA syntheses.

Nicolás L Calzetta, Sabrina F Mansilla, Candelaria Mares Ahlers

|Sep 13, 2025
Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast Cancer.

Kerstin Pfister, Sophia Huesmann, Angelina Fink

|Jul 08, 2025
Versatile enhancement of the killing potential of anti-cancer agents achieved by peptide mimetics of the PCNA interface towards specialized DNA polymerases.

Yiovana Verónica Okraine, María Belén de la Vega, Sofía Venerus Arbilla

Pageof 5

Frequent Collaborators

5 joint publications

Melanie Rall-Scharpf

5 joint publications

Vanesa Gottifredi

3 joint publications

Yitian Guo

3 joint publications

Thomas W P Friedl